Corvus Pharmaceuticals, Inc.'s President and CEO just disposed of 20,000 shares

Richard A Miller, Corvus Pharmaceuticals, Inc.'s President and CEO and a director of the company, recently disposed of 20,000 shares of the company. The disposals took place at $0.00 per share, on December 11, 2018. Miller still owns 1,098,795 shares of the company. At least some of the disposals which took place during this transaction were gifts or donations. Miller operates out of Burlingame, CA. Some additional info was provided as follows:

A portion of these shares is subject to a right of repurchase held by the Issuer.
These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shar es held by the Miller Horning Trust.
The underlying shares subject to the option vest as to one-forty eighth (1/48th) of the shares in successive, equal monthly installments measured from December 12, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Corvus Pharmaceuticals, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

On September - Sept. 17, 2020
Corvus Pharmaceuticals, Inc. director was just granted 30,000 options - Sept. 15, 2020
Corvus Pharmaceuticals, Inc. director just declared 0 ownership of the company. - Sept. 15, 2020
Departure of Directors or Certain - Sept. 11, 2020
On September - Sept. 10, 2020

Auto Refresh